Measles: Difference between revisions

No edit summary
Line 1: Line 1:
==Background==
==Background==
*Also known as Rubeola, which is not to be confused with German Measles ([[Rubella]])
*Also known as Rubeola, which is not to be confused with German Measles ([[Rubella]])
*10d incubation period
*3d prodromal period
*Patients are contagious from about 4 days before to 4 days after onset of rash
*Patients are contagious from about 4 days before to 4 days after onset of rash


===Current Outbreaks===
*2015
**Large scale outbreak linked to DisneyLand, CA: children through teenagers affected, 70 known cases
==Clinical Features==
[[File:Koplik's Spots on Cheek.jpg|thumb|Koplik's Spots on Cheek]]
[[File:Koplik's Spots on Cheek.jpg|thumb|Koplik's Spots on Cheek]]
[[File:Koplik's Spots on Palate.jpg|thumb|Koplik's Spots on Palate]]
[[File:Koplik's Spots on Palate.jpg|thumb|Koplik's Spots on Palate]]
[[File:Measle's Rash on Face.jpg|thumb|Measle's Rash on Face]]
[[File:Measle's Rash on Face.jpg|thumb|Measle's Rash on Face]]
[[File:Measle's Rash on on Thorax.jpg|thumb|Measle's Rash on on Thorax]]
[[File:Measle's Rash on on Thorax.jpg|thumb|Measle's Rash on on Thorax]]
==Clinical Features==
*Consider measles in a patient of any age who has an acute RASH and FEVER
*Consider measles in a patient of any age who has an acute RASH and FEVER
*Typically begins with a prodrome of high [[fever]], cough, coryza, and [[conjunctivitis]]
*Incubation period - 10 days
*Koplik's spots (appears day 2-3)
*Prodrome of high [[fever]], cough, coryza, and [[conjunctivitis]] (lasts ~3 days)
**Pathognomonic enanthem
*Koplik's spots (appears day 2-3) - pathognomonic enanthem
**Tiny red spots (base) with bluish-white centers on the mucosa of the cheek or palate
**Tiny red spots (base) with bluish-white centers on the mucosa of the cheek or palate
*Rash (begins day 4 - lasts to day 7)
*Rash (begins day 4 - lasts to day 7)
Line 29: Line 24:
{{Peds Rash DDX}}
{{Peds Rash DDX}}


==Work Up==
==Diagnostic Evaluation==
*Usually you need (check with your lab):
*Measles IgG and IgM
**Blood: 5-10 mL for measles IgG and IgM
*Culture and PCR of nasopharyngeal swab
***Use a red-top tube and spin down serum if possible
*Urine PCR
**Swabs: nasopharyngeal (or throat) for culture and PCR
***Use a viral culturette with viral transport media
**Urine: 50-100 mL of urine for PCR
***Use a sterile container


==Management==
==Management==
Line 44: Line 35:
===[[Isolation precautions|Isolation Precautions]]===
===[[Isolation precautions|Isolation Precautions]]===
*For suspected patients
*For suspected patients
**MASK the patient and ISOLATE immediately in an airborne infection isolation room
**Mask the patient and isolate immediately in an airborne infection isolation room
**All personnel entering the room should use respiratory protection at least as effective as an N95 respirator
**All personnel entering the room should use respiratory protection at least as effective as an N95 respirator
**If possible, allow only personnel with documentation of 2 doses of live measles vaccine or laboratory evidence of immunity (measles IgG positive) to enter the room
**If possible, allow only personnel with documentation of 2 doses of live measles vaccine or laboratory evidence of immunity (measles IgG positive) to enter the room
Line 50: Line 41:


===Post-Exposure Prophylaxis (Non-Immune Contact)===
===Post-Exposure Prophylaxis (Non-Immune Contact)===
*Immunocompetent:
*Immunocompetent:
**Within 72 hours of exposure use MMR vaccine
**MMR Vaccine (within 72 hours of exposure)
*Immunocompromised, children <12 months, and others at high risk of complications:   
*Immunocompromised, children <12 months, and others at high risk of complications:   
**IM Immune globulin (up to 6 days after exposure)
**Consider checking with your local health authorities
**Consider checking with your local health authorities
**Up to 6 days after exposure use IM immune globulin


==Complications==
==Complications==
*Severe illness can include [[pneumonia]], [[encephalitis]], and death
*Severe illness can cause [[pneumonia]], [[encephalitis]], and death


==See Also==
==See Also==
*[[Pediatric Rashes]]
*[[Pediatric Rashes]]


==Source==
==References==
*2/3/15 VEP HEALTH ADVISORY by Rob Wyman, MD
<references/>


[[Category:ID]]
[[Category:ID]]
[[Category:Derm]]
[[Category:Derm]]
[[Category:Peds]]
[[Category:Peds]]

Revision as of 08:09, 7 September 2015

Background

  • Also known as Rubeola, which is not to be confused with German Measles (Rubella)
  • Patients are contagious from about 4 days before to 4 days after onset of rash
Koplik's Spots on Cheek
Koplik's Spots on Palate
Measle's Rash on Face
Measle's Rash on on Thorax

Clinical Features

  • Consider measles in a patient of any age who has an acute RASH and FEVER
  • Incubation period - 10 days
  • Prodrome of high fever, cough, coryza, and conjunctivitis (lasts ~3 days)
  • Koplik's spots (appears day 2-3) - pathognomonic enanthem
    • Tiny red spots (base) with bluish-white centers on the mucosa of the cheek or palate
  • Rash (begins day 4 - lasts to day 7)
    • Red, blotchy, and maculopapular; rapidly progresses to confluence
    • Usually starts on the face (hairline and behind the ears)
    • Rapidly spreads to the chest, back, and finally the legs and feet
    • Rash resolves in order of appearance between days 7-9
  • Obtain a history of measles immunization, contact with known outbreak, travel outside of the Americas, or contact with international travelers in recent weeks

Differential Diagnosis

Pediatric Rash

Diagnostic Evaluation

  • Measles IgG and IgM
  • Culture and PCR of nasopharyngeal swab
  • Urine PCR

Management

  • Alert local health department ASAP
    • The risk of measles transmission to others and large contact investigations can be reduced if control measures are implemented immediately

Isolation Precautions

  • For suspected patients
    • Mask the patient and isolate immediately in an airborne infection isolation room
    • All personnel entering the room should use respiratory protection at least as effective as an N95 respirator
    • If possible, allow only personnel with documentation of 2 doses of live measles vaccine or laboratory evidence of immunity (measles IgG positive) to enter the room
    • Do not use the room for at least 2 hours after the patient leaves.

Post-Exposure Prophylaxis (Non-Immune Contact)

  • Immunocompetent:
    • MMR Vaccine (within 72 hours of exposure)
  • Immunocompromised, children <12 months, and others at high risk of complications:
    • IM Immune globulin (up to 6 days after exposure)
    • Consider checking with your local health authorities

Complications

See Also

References